✦ LIBER ✦

The impact of weight gain associated with atypical antipsychotic use in schizophrenia

✍ Scribed by Pierre Chue; Raphael Cheung

Book ID: 110755965
Publisher: John Wiley and Sons
Year: 2004
Tongue: Dutch
Weight: 137 KB
Volume: 16
Category: Article
ISSN: 0924-2708
DOI: 10.1111/j.0924-2708.2004.00067.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of atypical antipsychotic-ind

Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate

✍ YI-HSIUNG LIN; CHIA-YIH LIU; MEI-CHUN HSIAO 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB

The Impact of Atypical Antipsychotic Med

The Impact of Atypical Antipsychotic Medications on the Use of Health Care by Patients with Schizophrenia

✍ Lei Chen; Jeffrey S. McCombs; Jinhee Park 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Treatment of depressive mood in schizoph

Treatment of depressive mood in schizophrenia with the atypical antipsychotic quetiapine

✍ Hani Raoul Khouzam 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB 👁 2 views

Two patients with schizophrenia and depressive mood experienced remission in both their psychotic and depressive symptoms during treatment with the atypical antipsychotic quetiapine. These case reports illustrate the antipsychotic clinical efficacy of quetiapine and its antidepressant effects in the

The use of atypical antipsychotics in th

The use of atypical antipsychotics in the treatment of schizophrenia in North Staffordshire

✍ Richard Hodgson; R. Belgamwar; Yasin Al-tawarah; G. MacKenzie 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

## Aims: To examine the long-term effectiveness of atypical antipsychotics in a naturalistic setting for patients with schizophrenia. ## Method: A retrospective analysis of atypical antipsychotic prescribing in one health district between 1994 and 2001. time to discontinuation of the first atypic

Atypical Antipsychotic Medication and Su

Atypical Antipsychotic Medication and Substance Use-Related Outcomes in the Treatment of Schizophrenia

✍ Ismene L. Petrakis; Douglas Leslie; John W. Finney; Robert Rosenheck 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 80 KB

Neuroleptic malignant syndrome associate

Neuroleptic malignant syndrome associated with the use of risperidone, an atypical antipsychotic agent

✍ Heidi Lee; James Ryan; George Mullett; Brian A. Lawlor 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

Neuroleptic malignant syndrome (NMS) is a rare and sometimes fatal adverse reaction to neuroleptic drugs. Atypical antipsychotic agents, such as risperidone, are thought to be less likely to cause N M S because of their phamacologiical profile. This is a case report of NMS associated with risperidon